Use of buprenorphine for addiction treatment: Perspectives of addiction specialists and general psychiatrists

Psychiatric Services

Volumn 59, Issue 8, 2008, Pages 909-916

  Thomas, Cindy Parks ^a   Reif, Sharon ^a   Haq, Sayeda ^a   Wallack, Stanley S ^a   Hoyt, Alexander ^a   Ritter, Grant A ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE;

ADDICTION; ARTICLE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; INTERNET; MEDICAL SPECIALIST; OPIATE ADDICTION; PRESCRIPTION; PSYCHIATRIST;

EID: 50149103550     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2008.59.8.909     Document Type: Article

References (18)

1. Physician Waiver Qualifications. Rockville, Md, Substance Abuse and Mental Health Services Administration. Available at www.buprenorphine.samhsa.gov
2. Thomas CP, Wallack SS, Lee S, et al: Research to practice: adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 24:1-11, 2003
3. Mark TL, Kranzler HR, Poole VH, et al: Barriers to the use of medications to treat alcoholism. American Journal on Addictions 12:281-294, 2003
4. The Determinations Report: A Report on the Physician Waiver Program Established by the Drug Addiction Treatment Act of 2000 ("DATA"). Rockville, Md, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, 2006
5. Stanton A, McLeod C, Luckey B, et al: SAMHSA/CSAT Evaluation of the Buprenorphine Waiver Program. Presented at the annual research meeting of the American Society of Addiction Medicine, San Diego, May 5-7, 2006
6. West JC, Kosten TR, Wilk J, et al: Challenges in increasing access to buprenorphine treatment for opiate addiction. American Journal on Addictions 13(suppl 1):S8-S16, 2004
7. Koch AL, Arfken CL, Schuster CR: Characteristics of US substance abuse treatment facilities adopting buprenorphine in its initial stage of availability. Drug and Alcohol Dependence 83:274-278, 2006
8. National Survey on Drug Use and Health, 2005. Rockville, Md, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2006. Available at www.icpsr.umich.edu/cocoon/ICPSR/STUDY/04596.xml
9. O'Connor PG, Fiellin DA: Pharmacologic treatment of heroin-dependent patients. Annals of Internal Medicine 133:40-54, 2000
10. Hser YI, Maglione M, Polinsky ML, et al: Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 15:213-220, 1998
11. Subutex and Suboxone approved to treat opiate dependence. FDA Talk Paper. Rockville, Md, US Food and Drug Administration, 2002. Available at www.fda.gov/bbs/topics/answers/2002/ans01165.html
12. Johnson RE, Eissenberg T, Stitzer ML, et al: A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence 40:17-25, 1995
13. Fudala PJ, Bridge TP, Herbert S, et al: Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 1349:949-958, 2003
14. Rogers E: Diffusion of Innovations. New York, Free Press, 2003
15. Emergency Department Trends From DAWN: Final Estimates 1995-2002. ED Drug Episodes: Estimated Rates per 100,000 Population by Metropolitan Area by Half Year, Table 13.1. Rockville, Md, Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2002. Available at http://dawninfo.samhsa.gov/olddawn/pubs9402/edpubs/2002final/files/ pubtablesch13.xls
16. Wallack SS, Thomas CP, Martin TC, et al: Substance abuse treatment organizations as mediators of social policy. Journal of Behavioral Health Services and Research, in press
17. Pincus HA, Zarin DA, Tanielian TL, et al: Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry 56:441-449, 1999
18. Wilk J, Marcus SC, West J, et al: Substance abuse and the management of medication nonadherence in schizophrenia. Journal of Nervous and Mental Disease 194:454-457, 2006